Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Report Description
Extracorporeal membrane oxygenation (ECMO) assists cardiopulmonary functions outside the body. Based on the location of drainage and reinfusion there are 3 different types of extracorporeal membrane oxygenation system which are arteriovenous, venoarterial and venovenous whereas on the bases of age, it is classified into neonatal, pediatric and adult. The growing number of congenital heart defects, increase the demand for ECMO. For instance, according to American Heart Association, approximately 40,000 babies are born with a congenital heart defect in United States each year and around 2 to 3 million individuals are living with a congenital heart defect.
Market Dynamics
The growth of ECMO market is due to factors like increasing prevalence of cardiovascular and chronic respiratory disease such as asthma, chronic obstructive pulmonary disease (COPD), occupational lung disease or pulmonary hypertension. For instance, in 2014, Centers for Disease Control and Prevention (CDC) reported 1,417,101 deaths globally due to chronic respiratory disease. Moreover, increasing implementation of ECMO will also swell the ECMO system market. According to National Center for Biotechnology Information, ECMO is effective and growing means of life support for the patients with swine flu infection by bridging the gap, between respiratory distress to total body recovery. Further, medical policies such as Premera, supports extracorporeal membrane oxygenation (ECMO) in adults may be considered medically necessary for the management of acute respiratory failure. On the flip side of the coin, the ECMO system market is expected to be hampered by the complications associated with the ECMO system such as internal bleeding, blood clotting or technical failure.
Key features of the study:
• This report provides in-depth analysis of the extracorporeal membrane oxygenation system market and its application, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global extracorporeal membrane oxygenation (ECMO) system market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
• Key companies covered as a part of this study include Medtronic plc., Getinge Group, LivaNova Plc., Terumo Corporation, Xenios AG, Microsoft Scientific Co., Origen Biomedical, Eurosets S.R.L., Nipro Corporation, Alung technologies Inc.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion and marketing tactics.
• The global extracorporeal membrane oxygenation (ECMO) system market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for extracorporeal membrane oxygenation system market, research and consulting firms, new entrants and financial analysts
Detailed Segmentation:
• Global Extracorporeal Membrane Oxygenation System Market, By Modality:
o Arteriovenous
o Venoarteial
o Venovenous
• Global Extracorporeal Membrane Oxygenation System Market, By Application:
o Extracorporeal cardiopulmonary resuscitation
o Cardiac
o Respiratory
• Global Extracorporeal Membrane Oxygenation System Market, By Age Group:
o Neonatal
o Pediatric
o Adults
• Global Extracorporeal Membrane Oxygenation System Market, By Region:
o North America
o By Country
o U.S.
o Canada
o By Modality
o Arteriovenous
o Venoarteial
o Venovenous
o By Application:
o Extracorporeal cardiopulmonary resuscitation
o Cardiac
o Respiratory
o By Age Group:
o Neonatal
o Pediatric
o Adults
o Europe
o By Country
o Germany
o UK
o France
o Spain
o Russia
o Rest of Europe
o By Modality
o Arteriovenous
o Venoarteial
o Venovenous
o By Application:
o Extracorporeal cardiopulmonary resuscitation
o Cardiac
o Respiratory
o By Age Group:
o Neonatal
o Pediatric
o Adults
o Asia-Pacific
o By Country
o China
o India
o South Korea
o Japan
o Australia
o ASEAN
o Rest of Asia-Pacific
o By Modality
o Arteriovenous
o Venoarteial
o Venovenous
o By Application:
o Extracorporeal cardiopulmonary resuscitation
o Cardiac
o Respiratory
o By Age Group:
o Neonatal
o Pediatric
o Adults
o Latin America
o By Country
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o By Modality
o Arteriovenous
o Venoarteial
o Venovenous
o By Application:
o Extracorporeal cardiopulmonary resuscitation
o Cardiac
o Respiratory
o By Age Group:
o Neonatal
o Pediatric
o Adults
o Middle East
o By Country
o GCC
o Israel
o Rest of Middle East
o By Modality
o Arteriovenous
o Venoarteial
o Venovenous
o By Application:
o Extracorporeal cardiopulmonary resuscitation
o Cardiac
o Respiratory
o By Age Group:
o Neonatal
o Pediatric
o Adults
o Africa
o By Country
o North Africa
o Central Africa
o South Africa
o By Modality
o Arteriovenous
o Venoarteial
o Venovenous
o By Application:
o Extracorporeal cardiopulmonary resuscitation
o Cardiac
o Respiratory
o By Age Group:
o Neonatal
o Pediatric
o Adults
• Company Profiles
o Medtronic plc. *
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments
o Strategies
o Getinge Group
o LivaNova Plc.
o Terumo Corporation
o Xenios AG
o Microsoft Scientific Co.
o Origen Biomedical
o Eurosets S.R.L.
o Nipro Corporation
o Alung technologies Inc.
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
• Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
• Market Overview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Modality
o Market Snippet, By Application
o Market Snippet, By Age Group
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
• Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Technological Advancements
o Industry Trends
o PEST Analysis
o PORTER'S Five Forces
• Global Extracorporeal Membrane Oxygenation System Market, By Modality, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2017 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Arteriovenous
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Venoarteial
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Venovenous
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
• Global Extracorporeal Membrane Oxygenation System Market, By Application, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2017 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Extracorporeal cardiopulmonary resuscitation
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Cardiac
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Respiratory
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
• Global Extracorporeal Membrane Oxygenation System Market, By Age Group, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2017 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Neonatal
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Pediatric
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Adults
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
• Global Extracorporeal Membrane Oxygenation System Market, By Region, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2017 and 2025 (%)
o Y-o-Y Growth Analysis, By Region, 2016 - 2026
o Regional Trends
o North America
o Market Size and Forecast, By Modality, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Age Group, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• U.S.
• Canada
o Europe
o Market Size and Forecast, By Modality, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Age Group, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Modality, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Age Group, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• China
• Japan
• India
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
o Latin America
o Market Size and Forecast, By Modality, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Age Group, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• Brazil
• Mexico
• Rest of Latin America
o Middle East
o Market Size and Forecast, By Modality, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Age Group, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• GCC Countries
• Israel
• Argentina
• Rest of Middle East
o Africa
o Market Size and Forecast, By Modality, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Age Group, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
• Northern Africa
• Central Africa
• South Africa
• Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profiles
o Medtronic Plc.
• Company Overview
• Product Type Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
o Getinge Group
• Company Overview
• Product Type Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
o LivaNova Plc.
• Company Overview
• Product Type Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
o Terumo Corporation
• Company Overview
• Product Type Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
o Xenios AG
• Company Overview
• Product Type Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
o Microsoft Scientific Co.
• Company Overview
• Product Type Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
o Origen Biomedical
• Company Overview
• Product Type Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
o Eurosets S.R.L.
• Company Overview
• Product Type Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
o Nipro Corporation
• Company Overview
• Product Type Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
o Alung technologies Inc.
• Company Overview
• Product Type Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Section
o References
o Analyst Views
o Research Methodology
o About Us and Sales Contact
*Browse 36 market data tables and 32 figures on "Extracorporeal Membrane Oxygenation System Market - Global forecast to 2026".
